
	September 26, 2026		December 27, 2025
Revolving loans	$	9,000	$	36,000
Senior Term Loan, due 2028	—		636,960
Senior Term Loan, due 2033	935,000		—
Finance lease & other obligations	23,718		20,090
	967,718		693,050
Unamortized discount on Senior Term Loan	(3,544)		(2,087)
Current portion of long-term debt and finance leases	(16,292)		(14,830)
Deferred financing fees	(7,370)		(7,796)
Total long-term debt, net	$	940,512	$	668,337

As of September 26, 2026, the Asset-Backed Loan ("ABL") Revolver had an outstanding balance of $9,000, and had outstanding letters of credit of $5,350. Certain portions of the ABL Revolver are separately available to the Company’s United States and Canadian subsidiaries. Canada has no outstanding borrowings and the United States has outstanding borrowings of $9,000. The Company has $308,030 of available borrowings under the revolving credit facility as a source of liquidity as of September 26, 2026 based on the customary ABL borrowing base and availability provisions.

On July 22, 2026, the Company entered into a new Term Loan B and new asset based revolving credit facility consisting of a $735 million senior secured Term Loan B (the "New Term Loan"), maturing 2033 and a $375 million senior secured asset-based revolving credit facility (the "New ABL Facility”), maturing 2031. The net proceeds of

the transaction were used to refinance the Company's existing Term Loan B due 2028, pay down the existing ABL facility due 2027, as well as pay down the related fees and expenses, and for general corporate purpose.

In connection with the completion of the acquisition of Kanebridge, on August 28, 2026, the Company entered into Amendment No. 1 (the “First Amendment”) to provide for an additional $200 million of senior secured Additional Term Loans, the proceeds of which were used, together with cash on hand and borrowings under the Company's existing revolving credit facility, to finance a portion of the consideration paid to acquire Kanebridge and to pay related fees and expenses. These Additional Term Loans were made on the same terms and maturity as the Company’s existing senior secured term loans maturing July 22, 2033. Following the effectiveness of the First Amendment, the aggregate principal amount outstanding under the Company's term loan facility was approximately $935 million.

The interest rate per annum applicable to the Term Loan outstanding is SOFR plus a margin of 2.00%, as well as a 1.00% margin for ABR Loans and a 1% prepayment premium for the New Term Loan to apply to Repricing Transactions that occur within six months after the effective date. In connection with the closing of the First Amendment and New Term Loan, the Company expensed $13,505 consisting of $1,488 of existing fees written off and $12,017 in new fees expensed. The Company capitalized an additional $3,751 primarily for the payment of upfront lender fees and original issue discount.

On January 14, 2025, the Company entered into a Repricing Amendment (2025 Repricing Amendment) on its prior Senior Term Loan due July 14, 2028. The 2025 Repricing Amendment (i) reduced the interest rate per annum applicable to the Term Loan outstanding from SOFR plus a margin varying from 2.25% to 2.50% to SOFR plus a margin of 2.00%, as well as a 1.00% margin for ABR Loans and (ii) implemented a 1% prepayment premium for the existing Term Loan to apply to Repricing Transactions that occur within six months after the effective date of the 2025 Repricing Amendment. In connection with the closing of the 2025 Repricing Amendment, the Company expensed $906 of new fees in 2025.